According to a new market report published by Lucintel, the future of the human microbiome market looks promising with opportunities in the therapeutic industry. The global human microbiome market is expected to grow with a CAGR of 23% from 2020 to 2025. The major drivers for this market are rise in advanced technology, increase in the aging population, rise in incidences of chronic diseases, and regulations by governmental bodies on probiotics and prebiotics.
To download report brochure, please go to https://www.lucintel.com/human-microbiome-market.aspx and click "download brochure" tab from the menu
The human microbiome is the aggregate of all microbiota that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. In this market, proteomics, metabolomics, and genomics are the major research technologies of human microbiome. Lucintel forecasts that genomics will remain the largest research technology segment over the forecast period due to increasing number of projects funded by private and government bodies.
Within this market, therapeutic will remain the largest application segment over the forecast period due to the increase in funding for R&D into microbiome-based therapies.
North America is expected to witness the highest growth over the forecast period due to increasing incidences of lifestyle diseases, rising awareness of preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products.
Enterome Bioscience, Seres Therapeutics, 4D Pharma, Rebiotix, Yakult Honsha, Osel, Vedanta Biosciences, Synthetic Biologics, DuPont, and BiomX are among the major suppliers in the global human microbiome market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global human microbiome market by product, disease, application, research technology, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Human Microbiome Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global human microbiome market by product, disease, application, research technology, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Prebiotic
Probiotic
Food
Medical Food
Drug
By Disease [Value ($ Million) shipment analysis for 2014 – 2025]:
Infectious
Metabolic/Endocrine
Cancer
Blood
Neurological
By Research Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Proteomics
Metabolomics
Genomics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
China
India
Japan
Indonesia
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.